|
97
|
299
|
4at4A |
Crystal structure of trkb kinase domain in complex with ex429 |
|
79
|
283
|
4bb4A |
Ephb4 kinase domain inhibitor complex |
|
74
|
265
|
4b8lA |
Aurora b kinase p353g mutant |
|
76
|
298
|
4bcqA |
Structure of cdk2 in complex with cyclin a and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
99
|
299
|
4b4lA |
Crystal structure of an ard dap-kinase 1 mutant |
|
85
|
303
|
4bdkA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
18
|
106
|
4bjjA |
Sfc1-sfc7 dimerization module |
|
102
|
312
|
4asdA |
Crystal structure of vegfr2 (juxtamembrane and kinase domains) in complex with sorafenib (bay 43-9006) |
|
87
|
321
|
4bcgA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
78
|
279
|
4bi2A |
Scaffold focused virtual screening: prospective application to the discovery of ttk inhibitor |
|
80
|
273
|
4as0A |
Cyclometalated phthalimides as protein kinase inhibitors |
|
99
|
303
|
4b9dA |
Crystal structure of human nima-related kinase 1 (nek1) with inhibitor. |
|
82
|
271
|
4bieA |
Crystal structures of ask1-inhibitor complexes |
|
92
|
281
|
4b6lA |
Discovery of oral polo-like kinase (plk) inhibitors with enhanced selectivity profile using residue targeted drug design |
|
80
|
299
|
4bckA |
Structure of cdk2 in complex with cyclin a and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
82
|
303
|
4bdcA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
76
|
282
|
4aw5A |
Complex of the ephb4 kinase domain with an oxindole inhibitor |
|
88
|
304
|
4bddA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
81
|
270
|
4bidA |
Crystal structures of ask1-inhibitor complexes |
|
77
|
293
|
4aw1A |
Human pdk1 kinase domain in complex with allosteric compound ps210 bound to the pif-pocket |
|
97
|
299
|
4at3A |
Crystal structure of trkb kinase domain in complex with cpd5n |
|
100
|
347
|
4b99A |
Crystal structure of mapk7 (erk5) with inhibitor |
|
95
|
350
|
4b7tA |
Glycogen synthase kinase 3 beta complexed with axin peptide and leucettine l4 |
|
84
|
321
|
4bchA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
141
|
445
|
4azwA |
Crystal structure of monomeric wbdd. |
|
134
|
435
|
4axfA |
Insp5 2-k in complex with ins(3,4,5,6)p4 plus amppnp |
|
89
|
304
|
4bdgA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
99
|
299
|
4at5A |
Crystal structure of trkb kinase domain in complex with gw2580 |
|
78
|
293
|
4bc6A |
Crystal structure of human serine threonine kinase-10 bound to novel bosutinib isoform 1, previously thought to be bosutinib |
|
87
|
299
|
4bcpA |
Structure of cdk2 in complex with cyclin a and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
135
|
434
|
4axeA |
Inositol 1,3,4,5,6-pentakisphosphate 2-kinase in complex with adp |
|
91
|
296
|
4bggA |
Crystal structure of the acvr1 kinase in complex with ldn-213844 |
|
152
|
470
|
4azsA |
High resolution (2.2 a) crystal structure of wbdd. |
|
87
|
303
|
4bdhA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
89
|
304
|
4bdeA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
79
|
285
|
4aw0A |
Human pdk1 kinase domain in complex with allosteric compound ps182 bound to the pif-pocket |
|
83
|
321
|
4bcjA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
78
|
291
|
4auaA |
Liganded x-ray crystal structure of cyclin dependent kinase 6 (cdk6) |
|
84
|
271
|
4bicA |
Crystal structures of ask1-inhibitor complexes |
|
127
|
437
|
4aqkA |
Inositol 1,3,4,5,6-pentakisphosphate 2-kinase in complex with adp and ip6 |
|
81
|
271
|
4bhnA |
Crystal structures of ask1-inhibitor complexes |
|
118
|
350
|
4azeA |
Human dyrk1a in complex with leucettine l41 |
|
147
|
470
|
4ax8A |
Medium resolution structure of the bifunctional kinase- methyltransferase wbdd |
|
76
|
266
|
4b0gA |
Complex of aurora-a bound to an imidazopyridine-based inhibitor |
|
80
|
269
|
4bf2A |
Crystal structures of ask1-inhibitor complexes |
|
112
|
337
|
4axaA |
Structure of pka-pkb chimera complexed with (1s)-2-amino-1-(4- chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol |
|
85
|
321
|
4bcfA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
81
|
298
|
4bghA |
Crystal structure of cdk2 in complex with pan-cdk inhibitor |
|
95
|
299
|
4aszA |
Crystal structure of apo trkb kinase domain |
|
146
|
468
|
4aztA |
Co-crystal structure of wbdd and kinase inhibitor ly294002. |
